Literature DB >> 26597467

Comparison of Index Hospitalization Costs Between Robotic CABG and Conventional CABG: Implications for Hybrid Coronary Revascularization.

Galina Leyvi1, Clyde B Schechter2, Sankalp Sehgal3, Mark A Greenberg4, Max Snyder3, Stephen Forest5, Alec Mais3, Nan Wang6, Patrice DeLeo5, Joseph J DeRose5.   

Abstract

OBJECTIVES: To compare the direct costs of the index hospitalization and 30-day morbidity and mortality incurred during robotic and conventional coronary artery bypass grafting at a single institution based on hospital clinical and financial records.
DESIGN: Retrospective study, propensity-matched groups with one-to-one nearest neighbor matching.
SETTING: University hospital, a tertiary care center. PARTICIPANTS: Two thousand eighty-eight consecutive patients who underwent primary coronary artery bypass grafting (CABG) from January 2007 to March 2012.
INTERVENTIONS: One hundred forty-one matched pairs were created and analyzed.
MEASUREMENTS AND MAIN RESULTS: Robotic CABG was associated with a decrease in operative time (5.61±1.1 v 6.6±1.15 hours, p<0.001), a lower need for blood transfusion (12.8% v 22.6%, p = 0.04), a shorter length of stay (6 [4-9]) v 7 [5-11] days, p = 0.001), a shorter ICU stay (31 [24-49] hours v 52 [32-96.5] hours, p<0.001) and lower NY state complications composite rate (4.26% v 13.48%, p = 0.01). In spite of that, the cost of robotic procedures was not significantly different from matched conventional cases ($18,717.35 [11,316.1-34,550.6] versus $18,601 [13,137-50,194.75], p = 0.13), except 26 hybrid coronary revascularizations in which angioplasty was performed on the same admission (hybrid 25,311.1 [18,537.1-41,167.85] versus conventional 18,966.13 [13,337.75-56,021.75], p = 0.02).
CONCLUSION: Robotically assisted CABG does not increase the cost of the index hospitalization when compared to conventional CABG unless hybrid revascularization is performed on the same admission.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CABG; PCI; coronary stent; healthcare costs; minimally invasive surgery; robotic surgery

Mesh:

Year:  2015        PMID: 26597467     DOI: 10.1053/j.jvca.2015.07.031

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  8 in total

1.  Users' guide to the surgical literature: how to assess an article using surrogate end points.

Authors:  Lucas Gallo; Cagla Eskicioglu; Luis H Braga; Forough Farrokhyar; Achilleas Thoma
Journal:  Can J Surg       Date:  2017-08       Impact factor: 2.089

2.  Factors causing prolonged mechanical ventilation and peri-operative morbidity after robot-assisted coronary artery bypass graft surgery.

Authors:  Huan Hsu; Hui-Chin Lai; Tsun-Jui Liu
Journal:  Heart Vessels       Date:  2018-07-13       Impact factor: 2.037

3.  Robot-assisted coronary artery bypass surgery: a systematic review and meta-analysis of comparative studies.

Authors:  Fadi Hammal; Fernanda Nagase; Devidas Menon; Imtiaz Ali; Jeevan Nagendran; Tania Stafinski
Journal:  Can J Surg       Date:  2020 Nov-Dec       Impact factor: 2.089

4.  The Year in Cardiothoracic and Vascular Anesthesia: Selected Highlights from 2019.

Authors:  Adam S Evans; Menachem M Weiner; Shahzad Shaefi; Prakash A Patel; Matthew M Townsley; Abirami Kumaresan; Jared W Feinman; Ashley V Fritz; Archer K Martin; Toby B Steinberg; J Ross Renew; Jane L Gui; Brian Radvansky; Himani Bhatt; Sudhakar Subramani; Archit Sharma; Jacob T Gutsche; John G Augoustides; Harish Ramakrishna
Journal:  J Cardiothorac Vasc Anesth       Date:  2019-11-09       Impact factor: 2.628

5.  Review of Contemporary Techniques for Minimally Invasive Coronary Revascularization.

Authors:  Ali Fatehi Hassanabad; Jimmy Kang; Andrew Maitland; Corey Adams; William D T Kent
Journal:  Innovations (Phila)       Date:  2021-06-03

6.  Clinical outcomes of patients with multivessel coronary artery disease treated with robot-assisted coronary artery bypass graft surgery versus one-stage percutaneous coronary intervention using drug-eluting stents.

Authors:  Chieh-Shou Su; Ching-Hui Shen; Keng-Hao Chang; Chih-Hung Lai; Tsun-Jui Liu; Kuan-Ju Chen; Tzu-Hsiang Lin; Yu-Wei Chen; Wen-Lieng Lee
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

7.  Detailed cost of robotic-assisted surgery in the Australian public health sector: from implementation to a multi-specialty caseload.

Authors:  Kate McBride; Daniel Steffens; Christina Stanislaus; Michael Solomon; Teresa Anderson; Ruban Thanigasalam; Scott Leslie; Paul G Bannon
Journal:  BMC Health Serv Res       Date:  2021-02-01       Impact factor: 2.655

Review 8.  Elective cardiac surgery during the COVID-19 pandemic: Proceed or postpone?

Authors:  Islam M Shehata; Amir Elhassan; Jai Won Jung; Ivan Urits; Omar Viswanath; Alan D Kaye
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2020-07-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.